Skip to Content


Active Substance: aliskiren
Common Name: aliskiren
ATC Code: C09XA02
Marketing Authorisation Holder: Novartis Europharm Ltd.
Active Substance: aliskiren
Status: Withdrawn
Authorisation Date: 2007-08-22
Therapeutic Area: Hypertension
Pharmacotherapeutic Group: Agents acting on the renin-angiotensin system

Therapeutic Indication

Treatment of essential hypertension

The marketing authorisation for Enviage has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.